BRPI0608042A2 - compositions comprising actinidia and methods for the use of this - Google Patents

compositions comprising actinidia and methods for the use of this

Info

Publication number
BRPI0608042A2
BRPI0608042A2 BRPI0608042-1A BRPI0608042A BRPI0608042A2 BR PI0608042 A2 BRPI0608042 A2 BR PI0608042A2 BR PI0608042 A BRPI0608042 A BR PI0608042A BR PI0608042 A2 BRPI0608042 A2 BR PI0608042A2
Authority
BR
Brazil
Prior art keywords
fruit
kiwi
preparation
mammal
actinidia
Prior art date
Application number
BRPI0608042-1A
Other languages
Portuguese (pt)
Inventor
Julianne Lindemann
George E Stagnitti
Robert H Driver
Mark A Braman
Nacy E Fogg-Johnson
Sunyoung Kim
Mirim Jin
Hyung-Jin Jung
Sung-Seup Shin
Jin-Hwan Oh
Hwa-Jun Lee
Hyang Jeon
Eun-Jin Park
Bongcheol Kim
Original Assignee
Pangenomics Co Ltd
Efficas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pangenomics Co Ltd, Efficas Inc filed Critical Pangenomics Co Ltd
Publication of BRPI0608042A2 publication Critical patent/BRPI0608042A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPOSIçõES COMPREENDENDO ACTINIDIA E MéTODOS PARA O USO DESTA. Onde uma configuração da presente invenção refere-se a um método para regular uma resposta imune em um mamífero; o método inclui administrar um preparo de kiwi resistente ao mamífero em uma quantia suficiente para regular uma resposta imune no mamífero, onde o preparo de kiwi resistente é selecionado a partir de: fruta fresca, fruta amassada, fruta fervida, fruta cozida, fruta espremida, fruta condensada, fruta seca e um concentrado de suco de kiwi resistente. Nesta configuração, o preparo de kiwi resistente não foi extraído; em um aspecto da configuração acima, o preparo e kiwi resistente é produzido por um método que inclui uma etapa de secagem da fruta.COMPOSITIONS UNDERSTANDING ACTINIDIA AND METHODS FOR USING THIS. Where one embodiment of the present invention relates to a method for regulating an immune response in a mammal; The method includes administering a mammal resistant kiwi preparation in an amount sufficient to regulate an immune response in the mammal, where the resistant kiwi preparation is selected from: fresh fruit, mashed fruit, boiled fruit, boiled fruit, squeezed fruit, condensed fruit, dried fruit and a tough kiwi juice concentrate. In this configuration, the tough kiwi preparation was not extracted; In one aspect of the above configuration, the sturdy kiwi preparation is produced by a method that includes a fruit drying step.

BRPI0608042-1A 2005-02-25 2006-02-24 compositions comprising actinidia and methods for the use of this BRPI0608042A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65683805P 2005-02-25 2005-02-25
US65683905P 2005-02-25 2005-02-25
PCT/US2006/006437 WO2006093793A2 (en) 2005-02-25 2006-02-24 Compositions comprising actinidia and methods of use thereof

Publications (1)

Publication Number Publication Date
BRPI0608042A2 true BRPI0608042A2 (en) 2009-11-03

Family

ID=36941647

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0608042-1A BRPI0608042A2 (en) 2005-02-25 2006-02-24 compositions comprising actinidia and methods for the use of this

Country Status (8)

Country Link
EP (1) EP1858535A4 (en)
JP (1) JP2008531584A (en)
AU (1) AU2006218875B2 (en)
BR (1) BRPI0608042A2 (en)
MX (1) MX2007010408A (en)
RU (1) RU2423139C2 (en)
TW (1) TWI385007B (en)
WO (1) WO2006093793A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080175888A1 (en) * 2005-02-25 2008-07-24 Julie Lindemann Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
DE102006055210A1 (en) * 2006-11-21 2008-05-29 Ionescu, John G., Dr. Dietary food with increased free radical binding effect
KR101141182B1 (en) 2009-05-12 2012-05-02 재단법인 제주테크노파크 Composition for Anti-inflammation
US9352008B2 (en) 2009-08-12 2016-05-31 Melaleuca, Inc. Dietary supplements and methods for treating pain and inflammation
JP4750202B2 (en) * 2009-10-16 2011-08-17 株式会社 藍匠 Method for producing health supplements using Sarnashi
WO2011081509A1 (en) * 2009-12-29 2011-07-07 Chavez Gabriela Nutritional compositions comprising fruit flakes containing docosahexaenoic acid
JP5688233B2 (en) * 2010-04-23 2015-03-25 ポーラ化成工業株式会社 TARC production inhibitor
JP6179840B2 (en) * 2011-11-30 2017-08-16 国立大学法人 岡山大学 Highly polar organic solvent extract from Sarnashi and its utilization
JP6242669B2 (en) * 2013-11-27 2017-12-06 日本メナード化粧品株式会社 Hyaluronic acid production promoter containing a sarnashi extract
CN105410588B (en) * 2015-11-06 2018-05-08 四川兴食尚科技有限公司 A kind of Kiwi berry effervescent tablet and its preparation process
AU2019272800A1 (en) * 2018-05-22 2020-12-03 N.V. Nutricia Biomarkers for improving nutrion for infants at risk

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242814A (en) * 1989-10-10 1993-09-07 Eli Lilly And Company Polyether antibiotic
DE19758090B4 (en) * 1997-12-18 2008-10-16 Maria Endres Composition and its use in cosmetics and medicine
WO2002079372A1 (en) * 2001-03-29 2002-10-10 Council Of Scientific And Industrial Research Process for the preparation of herbal wines from himalayan berriers
US6811796B2 (en) * 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
WO2003103415A1 (en) * 2002-06-07 2003-12-18 Ann De Wees Allen Novel sweetener compositions and methods of use
KR100615389B1 (en) * 2002-08-23 2006-08-25 (주)헬릭서 Health food comprising the extract of Actinidia arguta and related species for the prevention and improvement of allergic disease and non-allergic inflammatory disease

Also Published As

Publication number Publication date
MX2007010408A (en) 2008-03-25
AU2006218875B2 (en) 2012-08-09
WO2006093793A8 (en) 2008-03-27
RU2423139C2 (en) 2011-07-10
EP1858535A4 (en) 2012-05-02
AU2006218875A1 (en) 2006-09-08
WO2006093793A3 (en) 2006-12-07
TWI385007B (en) 2013-02-11
EP1858535A2 (en) 2007-11-28
TW200716226A (en) 2007-05-01
JP2008531584A (en) 2008-08-14
WO2006093793A2 (en) 2006-09-08
RU2007135365A (en) 2009-03-27

Similar Documents

Publication Publication Date Title
BRPI0608042A2 (en) compositions comprising actinidia and methods for the use of this
Ghasemzadeh et al. Optimization of reflux conditions for total flavonoid and total phenolic extraction and enhanced antioxidant capacity in pandan (Pandanus amaryllifolius Roxb.) using response surface methodology
DK1737300T3 (en) Addition of an additive to a product suitable for human consumption
AR060255A1 (en) FOOD PRODUCTS THAT INCLUDE INTACT PROTEINS
BRPI0814371A8 (en) DRINK BASED ON VEGETABLES AND/OR FRUIT WITH INCREASED STABILITY AND A METHOD FOR ITS PREPARATION
EA201001044A1 (en) MENT-ACTIVE FRACTION AND METHOD OF ITS PREPARATION
MX340405B (en) Nutritional emulsions comprising calcium hmb and soluble protein.
MY190273A (en) Dietary supplements and compositions for enhancing physical performance and energy levels
BR112012011604A2 (en) natural flavor enhancers and their method of production
DK1844667T3 (en) Beverage containing functional ingredients capable of preventing degenerative phenomena caused by oxidants
BR112014000868A2 (en) preparation of dried pulp from unprocessed raw materials
AR066068A1 (en) PLANT FABRIC WITH AN ALTERED CONTENT OF A FLAVONOID COMPONENT; METHOD TO OBTAIN AND USE
RU2018110600A (en) STEVIA EXTRACTS
RU2014111960A (en) METHOD FOR OBTAINING A CULTIVATED RED GINSENG ROOT
DK1768682T3 (en) Plant origin product comprising proanthocyanidins and process for their preparation
MX360572B (en) Antioxidant ingredient with low calorie content, method for obtaining same and use thereof.
AR105515A1 (en) SALT CONCENTRATE THAT INCLUDES INORGANIC SALT, FAT AND GELLAN GUM
EP1449440A3 (en) Preservation method for vegetable items, and particularly for fruit
Oh Antioxidant and Neuronal cell protective effects of Stachys sieboldii Miq. according to drying methods
PH12014000123B1 (en) Ready-to-eat, gluten-free and ketogenic coconut meat-based cereal
TH18984C3 (en) Process for preparing freshwater algae extract as a dietary supplement
HRP20070230B1 (en) Herbal composition for the prevention and treatmentofdiabetes mellitus type (i) and type (ii)
Alipour et al. EVALUATION OF ANTIOXIDANT PROPERTIES AND TOTAL PHENOLIC OF HYDROALCOHOLIC EXTRACT OF SAFFRON PETAL
WO2016075595A3 (en) Food products and processes for preparation thereof
Rao Development of grits from processed and unprocessed pearl millet and its utilization in product development

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.